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Abstract
Objective The aim of this study was to investigate the
value of a single stage with combined tri-endoscopic
(duodenoscopy, laparoscopy and choledochoscopy)
approach for patients with concomitant cholecystolithiasis
and choledocholithiasis.
Methods Fifty-three patients with combined gallbladder
stones and common bile duct stones from February 2014 to
April 2015 were randomized assigned to two groups: 29
patients underwent single-stage surgery with combined
duodenoscope, laparoscope and choledochoscope (com-
bined tri-endoscopic group), and 29 patients underwent
endoscopic sphincterotomy to remove common bile duct
stones followed by laparoscopic cholecystectomy several
days later (control group). The success rate of complete
stone removal, procedure-related complication, hospital
stay and the cost of hospitalization were compared between
the two groups.
Results Altogether, 53 patients (29 patients in combined
tri-endoscopic group and 24 patients in control group)
successfully underwent the surgery and ERCP procedure.
Three patients in the control group developed post-ERCP
pancreatitis. One case of bile leaking and one case of
residual stone were noted in the combined tri-endoscopic
group. There were no significant differences between the
two groups with regard to both complete stone removal
[96.6 % (28/29) vs. 100 % (24/24)] and procedure-related
complication rate [3.4 % (1/29) vs. 12.5 % (3/24)]
(p[ 0.05). No open surgery was required in either group.
There were significant differences between the two groups
with regard to hospital stay (6.72 ± 1.3 days vs.
10.91 ± 1.6 days, p\ 0.01) and cost of hospitalization
(15,724 ± 1613 CNY vs. 19,829 ± 2433 CNY, p\ 0.05).
Conclusion The single-stage combined tri-endoscopic
approach for concomitant cholecystolithiasis and choledo-
cholithiasis was just as safe and successful as the control
group. In addition, it resulted in a shorter hospital stay and
less cost.
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With the advent of laparoscopic surgery, the management
of concomitant gallbladder stones and common bile duct
(CBD) stones has moved from open operation to the
combination of laparoscopy and endoscopy. Laparoscopic
cholecystectomy (LC) combined with endoscopic spinc-
terotomy (EST) has rapidly become the procedure of
choice and is currently widely accepted [1–3]. Clinically,
this procedure involves two stages, ERCP and EST fol-
lowed by LC a few days later or vice versa. This may
potentially increase hospital stay and the cost of hospital-
ization. Here, we compared single stage with combined tri-
endoscopic approach using laparoscope, choledochoscope
and duodenoscope to the standard two-stage approach in
terms of success, complications, hospital stay and cost of
hospitalization. This research aimed to develop a more
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and Other Interventional Techniques 
Patients and methods
From February 2014 to April 2015, 58 patients with con-
comitant gallbladder and CBD stones confirmed on ultra-
sound, abdominal CT scan and MRCP examination were
admitted to our center. This study is a 1:1 randomized
controlled trial, which was originally designed to select 29
patients for either single-stage combined tri-endoscopic
group using laparoscope, choledochoscope and duodeno-
scope (combined tri-endoscopic group) or control group
who underwent ERCP ? EST with placement of ENBD
tube followed by LC (control group) using random number
table. Unfortunately, five patients in control group rejected
laparoscopic cholecystectomy after ERCP for stone
removal. These five patients were excluded from the study
as PPS (per protocol set) was adopted in the data analysis,
which can only be restricted to the participants who fulfill
the protocol in terms of the eligibility, interventions, and
outcome assessment. Therefore, there were 29 patients in
combined tri-endoscopic group and only 24 patients in
control group.
Exclusion criteria were as follows: intrahepatic biliary
stones; a common bile duct stone with the diameter larger
than 1.5 cm; patients older than 80 years old; severe car-
diopulmonary disease; and contraindications for anesthesia
and surgery. The benefits and risks of the procedures were
discussed with patients. Informed consents to both the
procedure and the study were obtained from all patients.
The Ethics Committee of Beijing Friendship Hospital,




Under general anesthesia, laparoscopic cholecystectomy
was performed. The distal cystic duct was ligated, and then,
the gallbladder was removed. Two different procedures were
used to remove the CBD stones according to the size of the
common bile duct stones and the width of the cystic duct.
For the patients with wider cystic ducts and CBD stones less
than 1 cm, direct choledochoscopic stone removal was
selected. Choledochoscope was inserted directly into the
dilated cystic duct under laparoscope, and CBD stones were
removed by a basket under direct vision (Fig. 1A, B). For
cases with larger CBD stones or narrow cystic ducts,
choledochotomy was undertaken, and then, stones were
removed by baskets following choledochoscopic explo-
ration. After it was confirmed by choledochoscopy that there
were no residual stones in the CBD, a guidewire was
inserted into the CBD via choledochoscope, which further
passed the duodenal papilla and arrived at the lumen of the
descending duodenum. Duodenoscope was inserted into the
duodenum, where the hydrophilic end of the guidewire was
caught and pulled out of the duodenoscope (Fig. 1C, D). An
endoscopic nasobiliary drainage (ENBD) tube was inserted
along the guidewire. The position of the ENBD tube was
confirmed by choledochoscope (Fig. 1E, F). For all the
patients in this group, ENBD tube was kept in place for
drainage and further observation. For the patients who
underwent choledocholithotomy, primary closure of CBD
was undertaken and no T tube was required.
Control group
Firstly, the patients underwent ERCP and EST for stone
removal at the Endoscopy Center. The duodenoscope was
inserted into the descending duodenum. After cannulation
of the bile duct was achieved, a guidewire was placed. The
presence of the CBD stone was confirmed by cholangiog-
raphy. EST or a combination of EST with CRE balloon
dilation was performed. Then, the CBD stones were
removed using a basket or balloon. An ENBD tube was
inserted and placed.
Then, 2–3 days after ERCP operation, cholangiography
was performed via the ENBD tube to demonstrate the
presence of residual stones. LC was applied to the patients
without residual CBD stones. Patients with residual stones
received LC combined with choledochoscopic stone
removal trans-cystic duct or choledocholithotomy. ENBD
tube was continued after LC. Surgery was postponed for
the patients who developed complications after ERCP.
Postoperative management
Patients in both groups were closely observed for symp-
toms, such as abdominal pain, fever and melena. Intra-
venous fluids and prophylactic antibiotics were
administered in both groups after LC. Abdominal signs,
complete blood count and serum amylase were monitored.
Postoperative complications were managed accordingly.
Three days postoperation, cholangiography was performed
via ENBD tube and the ENBD tube was removed if no
residual CBD stones were seen. Elective ERCP was per-
formed for residual CBD stones.
Outcome measures
Success rate of stone removal
Success was defined as no residual stones of CBD on
ENBD tube cholangiography after surgery. The patients
5616 Surg Endosc (2016) 30:5615–5620
123
with residual stones after ERCP in the control group were
not included.
Complications
Postoperative complications in the two groups, including
pancreatitis, cholangitis, abdominal infection, perforation,
bleeding and bile leakage were recorded. The diagnostic
criteria for post-ERCP pancreatitis (PEP) include serum
amylase three times or more the upper limit of normal,
measured 2 h after the procedure plus abdominal pain,
fever, nausea, vomiting or peritoneal sign [4]. We adopted
Ranson criteria [5] for severe acute pancreatitis. Acute
pancreatitis was managed with NPO, NG tube, continuous
intravenous somatostatin and antibiotics.
Hospital stay and cost
Hospital stay was recorded and the cost of hospitalization
was calculated for both groups.
Statistical analysis
Quantitative data were presented as the mean ± SD and
tested using a t test. Categorical variables were tested using
a Chi-square test. Statistical significance was assumed
when p\ 0.05.
Results
Fifty-three patients were enrolled in this trial. Twenty-nine
were assigned to combined tri-endoscopic group and 24 to
control group. Both groups were similar in age, gender and
size of CBD stones (Table 1).
Success rate
Successful completion of surgery was achieved in all 53
patients. No patients underwent conversion to an open pro-
cedure. Although post-ERCP showed small residual stones in
Fig. 1 Endoscopy view of various steps of performing single-stage
procedure with combined tri-endoscopic approach for patients with
concomitant gallbladder stones and CBD stones. A Choledochoscope
is inserted directly into the dilated cystic duct under laparoscopic
view. B Choledochoscopic view of common bile duct stone. C The
guidewire is inserted into the CBD via choledochoscope and arrived
at the lumen of the descending duodenum. D The hydrophilic end of
the guidewire is caught and pulled out of the duodenoscope. E An
ENBD tube is inserted along the guidewire. F The position of the
ENBD tube is confirmed by choledochoscope
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two patients in the control group, the stones were retrieved in
the following LC. Therefore, postoperative cholangiography
demonstrated no residual stones in the control group. In the
combined tri-endoscopic group, residual stones were present
in one patient. The patient underwent elective ERCP stone
removal. There was no significant difference in the success
rate of CBD stones clearance for the two groups [96.6 % (28/
29) vs. 100 % (24/24); p = 0.37]. Among the 29 patients in
the combined tri-endoscopic group, 23 patients underwent
stone removal via cystic duct (79.3 %) and six had a chole-
dochotomy (20.7 %). In the control group, 22 patients
underwent simple LC and two patients underwent further
stone removal via cystic duct. No patient in the control group
underwent choledochotomy.
Postoperative complications
Bile leakage was observed in one patient in the combined
tri-endoscopic group with daily drainage of 20–80 ml. Bile
leaking was resolved via JP drain after 3 days. Three
patients in the control group developed postoperative
pancreatitis and recovered after NPO, acid inhibition,
antibiotics and somatostatin management. There was no
cholangitis, abdominal infection, bleeding or perforation.
The complication rates showed no significant statistical
difference [3.4 % (1/29) vs. 12.5 % (3/24); p = 0.21].
Hospital stay and cost of hospitalization
The average hospital stay of the patients in combined tri-
endoscopic groupwas significantly shorter (6.72 ± 1.3 days)
than that of the patients in control group (10.91 ± 1.6 days)
(p\ 0.01). The average cost for combined tri-endoscopic
group was significantly lesser than that of control group
[15,724 ± 1613 CNY vs. 19,829 ± 2433 CNY; (p = 0.03)].
Discussion
Cholecystolithiasis concomitant with choledocholithiasis is
very common, which accounts for 6–20 % of cholelithiasis
[1]. The optimal timing and best method for removal of
CBD stones associated with gallbladder stones is still
controversial. LC is the standard treatment of choice for
cholecystolithiasis [3]. However, if it is combined with
CBD stones, the conventional management plan is open
cholecystectomy, choledocholithotomy and drainage with a
T tube. This procedure is more invasive with increased risk
of complications. Although trans-cystic duct direct chole-
dochoscopic stone removal under laparoscope can be per-
formed if the cystic duct is large enough or can be dilated,
most surgeons become uncomfortable dilating the cystic
duct beyond 8 mm in diameter. Stones larger than this are
more appropriately dealt with lithotripsy or choledo-
chotomy [6, 7]. ERCP is still a standard procedure to treat
CBD stones [1, 4]. However, if it is combined with gall-
bladder stones, the gallbladder left in place may have a
significant risk of stone migrating down to CBD again or
an attack of cholecystitis. Costamagna et al. [8] followed
334 CBD stones patients who underwent ERCP for stone
removal. They demonstrated the risk of recurrent CBD
stones and cholecystitis to be 11.1 and 5.8 %, respectively.
Similar results also were reported [9, 10].
With the advent of minimally invasive procedures, the
combination of laparoscopy, duodenoscopy and choledo-
choscopy is proven to be an effective approach for gall-
bladder stones concomitant with CBD stones. Currently,
the majority of cases of cholecystolithiasis with choledo-
cholithiasis have been treated via a two-step management
using combination of laparoscope, duodenoscope and
choledochoscope, that is, either preoperative ERCP/EST
followed by elective LC or LC followed by elective ERCP/
EST [11, 12]. Recently, modified tri-endoscopic manage-
ment has been raised. The procedure includes placing an
ENBD tube under duodenoscope, followed by LC and
stone removal via choledochoscopy. Postoperative ENBD
tube other than T tube is kept. The modified approach has
the advantages of high success rate of stone retrieval,
gallbladder removal and preservation of the function of
Oddi’s sphincter [13]. It also avoids the complications
related to T tube placement, such as displacement of the T
tube, bile leakage, infection and difficult removal. How-
ever, all the treatment plans mentioned above involve two-
stage management with ERCP and LC, which causes some
discomfort to the patients, an extended hospital stay and
increased cost of hospitalization. A single-step procedure
combining laparoscopic cholecystectomy, intraoperative
ERCP and EST was also investigated [14, 15], but intra-
operative cholangiography may not be feasible in some
centers.
Our study compared two different approaches of single-
stage combining laparoscopy, duodenoscopy and choledo-
choscopy and two-stage with ERCP ? EST followed by
LC and identified no significant difference in the success
rate of stone removal and treatment-related complications
Table 1 Patient data






20 9 61.3 ± 14.5 0.9 ± 0.43
Control group 15 9 63.5 ± 12.4 1.0 ± 0.33
p 0.62 0.58 0.88
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between the two approaches. The single-stage approach
had more advantages in terms of shorter hospital stay and
lower cost of hospitalization. Unlike ERCP, a retrograde
procedure which increases the incidence of pancreatitis, the
guidewire insertion in the single-stage approach was an
antegrade procedure which has less tissue injury to duo-
denal papilla. The wire traveled to common bile duct via
choledochoscopy, passed the ampulla of vater and arrived
at the lumen of the descending duodenum. The guidewire
was directed with ease under duodenoscope or even gas-
troscope. Then, an ENBD tube was inserted under the
guidance of the guidewire to the CBD. This method not
only avoided the risk of post-ERCP pancreatitis but also
preserved the function of the sphincter of Oddi. During the
procedure, the lights of the laparoscopy and choledo-
choscopy should be dimmed to provide an optimal visual
field for duodenoscopy, the cooperation and coordination
between the gastroenterologists and general surgeons
before and during the operation should be critical, and this
procedure may not be feasible in some facilities.
In the control group, two-stage operations were per-
formed, in the operating room and endoscopic center,
respectively, and three patients developed post-ERCP
pancreatitis. The hospital stay was significantly longer than
that of the single-stage group. With regard to other com-
plications, the replacement of T tube by ENBD tube
allowed the primary closure of the CBD, which in turn
decreased the incidence of bile leakage. Mild bile leaking
was observed only in one patient in the single-stage group
and resolved after conservative treatment. After ERCP, two
patients in the control group demonstrated small stones in
CBD on cholangiography, which was likely due to the
migration of gallstones from gallbladder to extrahepatic
bile duct. Therefore, trans-cystic exploration of CBD to
examine the residual stones is usually required during LC
in two-stage approach.
In our research, the diameters of the CBD stones in our
research were less than 1.5 cm, which made the stone
removal technically easier; 79.3 % (23/29) of patients
succeeded in trans-cystic stone removal in the single-stage
group. Further research will focus on trials with larger-
sized sample and wider inclusion criteria as well as com-
paring single-stage approach to open surgery and LC fol-
lowed by ERCP. With the improvement of facilities, trials
on the effectiveness of stone removal via EST during LC
will be considered.
In summary, the complementary advantages of the three
endoscopes, duodenoscope, laparoscope and choledocho-
scope, in single-stage approach render an effective, feasible
and safe procedure with fewer complications for con-
comitant gallbladder stones and CBD stones. Single-stage
approach reduces the number of procedures, decreases the
discomfort to the patients, shortens hospital stay and lowers
the cost of hospitalization.
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